Maximizing the motivational impact of feedback of lung cancer susceptibility on smokers’ desire to quit

Journal of Health Communication

Volumn 5, Issue 3, 2000, Pages 229-241

  McBride, Colleen M ^a   Halabi, Susan ^b   Bepler, Gerold ^a   Lyna, Pauline ^b   McIntyre, Lauren ^b   Lipkus, Isaac ^a   Albright, Jennifer ^a   O’Briant, Kathy ^a  

^a DUKE CANCER INSTITUTE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HUMAN; INTERPERSONAL COMMUNICATION; LUNG TUMOR; MALE; METHODOLOGY; MOTIVATION; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; RISK; SMOKING CESSATION; STATISTICAL MODEL;

ADULT; BIOLOGICAL MARKERS; COMMUNICATION; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MOTIVATION; ODDS RATIO; SMOKING CESSATION;

EID: 0034217884     PISSN: 10810730     EISSN: 10870415     Source Type: Journal    
DOI: 10.1080/10810730050131406     Document Type: Article

References (20)

1. AHCPR. (1996). Smoking Cessation Clinical Practice Guideline. JAMA, 275(16), 1270-1280.
2. Amos, C. I., Caporaso, N. E., & Weston, A. (1992). Host factors in lung cancer risk: A review of interdisciplinary. Cancer Epidemiology, Biomarkers & Prevention, 1(6), 505-513.
3. Armstrong, R. N. (1991). Glutathione S-transferases: Reaction mechanism, structure, and function. Chemical Research in Toxicology, 4(2), 131-140.
4. Audrain, J., Boyd, N. R., Roth, J., Main, D., Caporaso, N. F., & Lerman, C. (1997). Generic susceptibility testing in smoking-cessation treatment: Outcomes of a randomized trial. Addictive Behaviors, 22(6), 741-751.
5. Bandura, A. (1977). Social learning theory. Englewood Cliffs, NJ: Prentice-Hall.
6. Bauman, K. E., Bryan, E. S., Dent, C. W., & Koch, G. G. (1983). The influence of observing carbon monoxide level on cigarette public prenatal patients. American Journal of Public Health, 73(9), 1089-1091.
7. Curry, S. J. (1993). Self-help interventions for smoking cessation. Journal of Consulting and Clinical Psychology, 61(5), 790-803.
8. Geller, G., Botkin, J. R., Green, M. J., Press, N., Biesecker, B. B., Wilfond, B., Grana, G., Daly, M. B., Schneider, K., & Kahn, M. J. (1997). Genetic testing for susceptibility to adult-onset cancer. The content of informed consent. JAMA, 277(18), 1467-1474.
9. Janz, N. K., & Becker, M. H. (1984). The Health Belief Model: A decade later. Health Education Quarterly, 11(1), 1-47.
10. Lerman, C., Gold, K., Audrain, J., Lin, T. H., Boyd, N. R., Orleans, C. T., Wilfond, B., Louben, G., & Caporaso, N. (1997). Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: Effects on smoking-related cognitions, emotions, and behavior change. Health Psychology, 16(1), 87-99.
11. Leventhal, H. (1970). Findings and theory in the study of fear communications. Advances in Experimental Social Psychology, 5, 19-186.
12. London, S. J., Daly, A. K., Cooper, J., Navidi, W. C., Carpenter, C. L., & Idle, J. R. (1995). Polymorphism of glutathione S-transferase M1 and lung cancer risk African-Americans and Caucasians in Los Angeles County, California. Journal of the National Cancer Institute, 87(16), 1246-1253.
13. McBride, C. M., Curry, S. J., Grothaus, L., Nelson, J. C., Lando, H., & Pirie, P. L. (1998). Partner smoking status and pregnant smoker’s perceptions of support for and likelihood of smoking cessation. Health Psychology, 17(1), 63-69.
14. McWilliams, J. E., Sanderson, B. J., Harris, E. L., Richert-Boe, K. E., & Henner, W. D. (1995). Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiology, Biomarkers & Prevention, 4(6), 589-594.
15. Radloff, L. S. (1977). The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385-401.
16. Rand, C. S., Stitzer, M. L., Bigelow, G. E., & Mead, A. M. (1989). The effects of contingent payment and frequent workplace monitoring smoking abstinence. Addictive Behaviors, 14(2), 121-128.
17. Rebbeck, T. R. (1997). Molecular epidemiology of the human glutathione S-transferase GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiology, Biomarkers & Prevention, 6(9), 733-743.
18. Scott, R. R., Prue, D. M., Denier, C. A., & King, A. C. (1986). Worksite smoking intervention with nursing professionals: Long-term outcome and relapse assessment. Journal of Consulting & Clinical Psychology, 54(6), 809-813.
19. Spitz, M. R., Hsu, T. C., Wu, X., Fueger, J. J., Amos, C. I., & Roth, J. A. (1995). Mutagen sensitivity as a biological marker of lung cancer risk in Americans. Cancer Epidemiology, Biomarkers & Prevention, 4(2), 99-103.
20. Weinstein, N. D. (1988). The precaution adoption process. Health Psychology, 7, 355-386.